Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
  • Leukemia
  • +3 more
    • Bethesda, Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike
    2022-04-07
    Apr 7, 2022
    N
    Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
    Completed
    • Multiple Myeloma
    • +3 more
      • Iowa City, Iowa
      • +1 more
      2022-04-07
      Apr 7, 2022
      N
      A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost...
      Recruiting
      • Solid Tumor Malignancy
      • +4 more
      • mRNA-1273
      • Bethesda, Maryland
      • +1 more
      2022-04-07
      Apr 7, 2022
      N
      Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
      Recruiting
      • Glioblastomas
      • +4 more
      • Enhanced Mindfulness Intervention
      • Psychoeducation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
      Recruiting
      • Leukemia
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-04-07
        Apr 7, 2022
        N
        Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
        Not yet recruiting
        • Lymphoma
        • Leukemia
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          2022-04-07
          Apr 7, 2022
          N
          Safety Study of Cord Blood Units for Stem Cell Transplants
          Recruiting
          • Aplastic Anemia
          • +3 more
          • Cord Blood Units
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-04-07
          Apr 7, 2022
          N
          Validating Pain Scales in Children and Young Adults
          Recruiting
          • Sickle Cell Disease
          • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-04-07
            Apr 7, 2022
            N
            Case-Control Study of Pesticides and Childhood Leukemia
            Completed
            • Leukemia
              • Berkeley, California
                University of California, Berkeley
              2022-04-07
              Apr 7, 2022
              S
              Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
              Recruiting
              • Hodgkin Lymphoma
              • +3 more
              • Biostrap arm band
              • Palo Alto, California
                Stanford University
              2022-03-29
              Mar 29, 2022
              F
              Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
              Not yet recruiting
              • Clinical Stage I Cutaneous Melanoma AJCC v8
              • +33 more
              • Informational Intervention
              • +4 more
              • Los Angeles, California
              • +4 more
              2022-04-04
              Apr 4, 2022
              M
              Better Leukemia Diagnostics Through AI (BELUGA)
              Recruiting
              • Hematologic Malignancy
              • +4 more
              • Automated AI-Guided Diagnosis of Hematological Malignancies
              • Munich, Bavaria, Germany
                MLL Munich Leukemia Laboratory
              2022-04-04
              Apr 4, 2022
              S
              A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
              Recruiting
              • Leukemia
              • Lymphoma
              • SCRI-CAR22v2
              • Los Angeles, California
              • +4 more
              2022-04-02
              Apr 2, 2022
              S
              A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
              Recruiting
              • Leukemia
              • Lymphoma
              • Patient-derived CD19- and CD22 specific CAR
              • Los Angeles, California
              • +4 more
              2022-04-02
              Apr 2, 2022
              B
              Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
              Not yet recruiting
              • Leukemia
              • IM19 CAR-T cells
              • (no location specified)
              2022-03-25
              Mar 25, 2022
              C
              A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
              Recruiting
              • Leukemia
              • Myelodysplastic Syndrome(MDS)
              • Duarte, California
              • +1 more
              2022-04-01
              Apr 1, 2022
              B
              3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
              Recruiting
              • Brain and Central Nervous System Tumors
              • +8 more
              • 3'-deoxy-3'-[18F]fluorothymidine
              • Detroit, Michigan
                Barbara Ann Karmanos Cancer Institute
              2022-03-30
              Mar 30, 2022
              F
              HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
              Recruiting
              • Juvenile Myelomonocytic Leukemia
              • +27 more
              • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
              • +2 more
              • Seattle, Washington
                Fred Hutch/University of Washington Cancer Consortium
              2022-03-16
              Mar 16, 2022
              C
              Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
              Active, not recruiting
              • Hematopoietic and Lymphoid System Neoplasm
              • +3 more
              • Allogeneic Hematopoietic Stem Cell Transplantation
              • +3 more
              • Birmingham, Alabama
              • +42 more
              2022-03-22
              Mar 22, 2022
              R
              Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer
              Recruiting
              • Pediatric Cancer
              • +5 more
              • Integrative neuromuscular training (INT)
              • +2 more
              • Aarhus, Denmark
              • +2 more
              2022-03-23
              Mar 23, 2022
              N
              Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia - 2021
              Terminated
              Has Results
              • Leukemia
              • +3 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              2022-03-11
              Mar 11, 2022
              M
              Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
              Recruiting
              • Solid Tumor
              • +3 more
              • Phoenix, Arizona
              • +8 more
              2022-03-21
              Mar 21, 2022
              D
              A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
              Active, not recruiting
              Has Results
              • Chronic Lymphocytic Leukemia
              • Leukemia
              • Coral Gables, Florida
              • +8 more
              2022-03-10
              Mar 10, 2022
              M
              A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies - 2022
              Withdrawn
              • Leukemia
              • +2 more
              • CAR T-Cell Infusion
              • New York, New York
                Memorial Sloan Kettering Cancer Center
              2022-03-04
              Mar 4, 2022
              C
              A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
              Recruiting
              • Myelofibrosis
              • +13 more
              • Phoenix, Arizona
              • +54 more
              2022-03-04
              Mar 4, 2022